|
Cell and gene therapies are entering a transformative era driven by the need for scalable, cost-effective, and safe gene editing technologies. Join us for an insightful webinar where experts from Integrated DNA Technologies (IDT) and Cytiva will present data demonstrating the potential of RNA-lipid nanoparticles (LNP)s for ex-vivo and in-vivo CRISPR gene editing.
link: Integrated DNA Technologies, Inc.
|
